Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure (PREVENTA)

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Blood Pressure

Study type

Observational

Funder types

Industry

Identifiers

NCT00925470
NIS-CFR-DUM-2009/1

Details and patient eligibility

About

Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.

Enrollment

1,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adults with hypertension (treated or not), without known cardiovascular or renal disease.

Trial design

1,200 participants in 1 patient group

1

Trial contacts and locations

375

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems